6Gallini A, J uillard-Condat B, Saux MC,et al. Drug selection in French university hospitals: Analysis of formularies for nine competitive pharmacological classes[J]. Brit J Clin Pharmaco, 2011, 72(5): 823-831.
7Sinha YK, Craig JC, Barclay P, etal. Drug approval processes in Australian paediatrie hospitals[J]. Arch Dis Child, 2010, 95 (9) : 739-744.
8Fijn R, Brouwers JR, Knaap RJ, et al. Drug and Therapeutics (D g> T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures[J]. Br J Clin Pharmacol, 1999, 48(2): 239-246.
9Puigventos F, Santos-Ramos B, Ortega A, et al. Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals[J]. Pharm World Sci, 2010, 32 (6) : 767- 775.
10Mittmann N, Knowles S. A survey of pharmacy and therapeu tic committees across Canada: scope and responsibilities[J]. Can J Clin Pharmacol, 2009, 16(1) : e171-e177.
